Evidence map›Paper›PMID 1835378›Full record

ArticleThe Biochemical journal1991

Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins.

M G Low, K S Huang

Abstract read
In one paragraph

Article in The Biochemical journal, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M G LowRover Physiology Research Laboratories, Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons of Columbia University, NY 10032.
K S Huang

Funding

PHOSPHATIDYLINOSITOL ANCHOR OF ALKALINE PHOSPHATASER01GM035873 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LOW, MARTIN G · 1986 to 1999
–
PHOSPHATIDYLINOSITOL MEMBRANE PROTEIN ANCHORSR01GM040083 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LOW, MARTIN G · 1989 to 1998
–
FUNCTION OF GPI-SPECIFIC PHOSPHOLIPASE DR55GM040083 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LOW, MARTIN G · 1994 to 1994
–
NIGMS NIH HHS GM-35873NIGMS NIH HHS GM-40083
6 · The paper itself

Abstract

Mammalian serum and plasma contain high levels of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD). Previous studies with crude serum or partially purified GPI-PLD have shown that this enzyme is capable of degrading the GPI anchor of several purified detergent-solubilized cell surface proteins yet is unable to act on GPI-anchored proteins located in intact cells. Treatment of intact ROS17/2.8, WISH or HeLa cells (or membrane fractions prepared from them) with GPI-PLD purified from bovine serum by immunoaffinity chromatography gave no detectable release of alkaline phosphatase into the medium. However, when membranes were treated with GPI-PLD in the presence of 0.1% Nonidet P-40 substantial GPI anchor degradation (as measured by Triton X-114 phase separation) was observed. The mechanism of this stimulatory effect of detergent was further investigated using [3H]myristate-labelled variant surface glycoprotein and human placental alkaline phosphatase reconstituted into phospholipid vesicles. As with the cell membranes the reconstituted substrates exhibited marked resistance to the action of purified GPI-PLD which could be overcome by the inclusion of Nonidet P-40. Similar results were obtained when crude bovine serum was used as the source of GPI-PLD. These data indicate that the resistance of cell membranes to the action of GPI-PLD is not entirely due to the action of serum or membrane-associated inhibitory factors. A more likely explanation is that, in common with many other eukaryotic phospholipases, the action of GPI-PLD is restricted by the physical state of the phospholipid bilayer in which the substrates are embedded. These data may account for the ability of endothelial and blood cells to retain GPI-anchored proteins on their surfaces in spite of the high levels of GPI-PLD present in plasma.

Indexed as

Alkaline PhosphataseAnimalsCattleCell LineCell MembraneChromatography, AffinityDetergentsGlycolipidsGlycosylphosphatidylinositolsHeLa CellsHumansLipid BilayersLiposomesMembrane ProteinsMyristic AcidMyristic AcidsAlkaline PhosphataseDetergentsGlycolipidsGlycosylphosphatidylinositolsLipid BilayersLiposomesMembrane ProteinsMyristic AcidMyristic AcidsPhosphatidylinositolsPhospholipase DVariant Surface Glycoproteins, Trypanosoma

Identifiers

PMID1835378
PMCPMC1151630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.